Characterization of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Among Iranian Kidney Transplant Patients

被引:38
|
作者
Halaji, Mehrdad [1 ,2 ]
Shahidi, Shahrzad [3 ]
Atapour, Abdolamir [3 ]
Ataei, Behrooz [4 ]
Feizi, Awat [5 ]
Havaei, Seyed Asghar [1 ,4 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Microbiol, Esfahan, Iran
[2] Isfahan Univ Med Sci, Nosocomial Infect Res Ctr, Esfahan, Iran
[3] Isfahan Univ Med Sci, Isfahan Kidney Dis Res Ctr, Esfahan, Iran
[4] Isfahan Univ Med Sci, Infect Dis & Trop Med Res Ctr, Esfahan, Iran
[5] Isfahan Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Esfahan, Iran
来源
INFECTION AND DRUG RESISTANCE | 2020年 / 13卷
关键词
UTIs; ESBL; PCR; KTP; URINARY-TRACT-INFECTION; KLEBSIELLA-PNEUMONIAE; CTX-M; MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; PREVALENCE; RESISTANCE; ENTEROBACTERIACEAE; GENES; SUSCEPTIBILITY;
D O I
10.2147/IDR.S248572
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The aim of this study was to investigate the antimicrobial susceptibility pattern and the presence of ESBLs among the uropathogenic Escherichia coli (UPEC) isolated from kidney transplant patients (KTP) and community-acquired urinary tract infections (UTIs) using phenotypic and molecular methods. Materials and Methods: A total of 111 pure cultures of UPEC isolates were collected from 65 and 46 of non-KTP and KTPs with UTIs. The pattern and ESBL production of the strains were evaluated. PCR reaction to detect the presence of bla(S)(HV), bla(TEM), and bla(C)(TX-M) genes was performed. Results: The results revealed that most of UPEC isolates obtained from KTPs and control group were resistant to trimethoprim/sulfamethoxazole (84.8% vs 46.2%), while carbapenems (100% sensitivity) were the most effective against UPEC isolates. ESBL-producing strains were significantly more frequent in KTPs compared with control group (43.5% vs 23.1%, P = 0.021). The molecular results revealed that 53.2% (59/111), 45% (50/111), and 5.4% (6/111) of isolates harbored bla(C)(TX-M), bla(TEM), and bla(S)(HV) genes, respectively. Of the genes investigated, bla(CTX-M) and bla(TEM) genes were significantly higher among KTP than the control group. Conclusion: Our results showed a high proportion of multidrug-resistant and ESBL-producing isolates, which most of them harbor blaCTX-M. A significant high co-resistance to different classes of antibiotics was reported from ESBL-producing UPEC from KTPs, which remains a serious clinical challenge.
引用
收藏
页码:1429 / 1437
页数:9
相关论文
共 50 条
  • [31] Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia
    Kao, Cheng-Yen
    Udval, Uuganbayar
    Huang, Yi-Ting
    Wu, Hsiu-Mei
    Huang, Ay-Huey
    Bolormaa, Enkhbaatar
    Yan, Jing-Jou
    Urangoo, Zorig
    Batbaatar, Gunchin
    Khosbayar, Tulgaa
    Wu, Jiunn-Jong
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (05) : 692 - 700
  • [32] Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco
    Barguigua, Abouddihaj
    El Otmani, Fatima
    Talmi, Mustapha
    Bourjilat, Fatna
    Haouzane, Fatima
    Zerouali, Khalid
    Timinouni, Mohammed
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (09) : 1344 - 1352
  • [33] Detection and characterization of extended-spectrum β-lactamase-producing Escherichia coli from chicken production chains in Nigeria
    Ojo, Olufemi E.
    Schwarz, Stefan
    Michael, Geovana B.
    VETERINARY MICROBIOLOGY, 2016, 194 : 62 - 68
  • [34] The first identification of an extended-spectrum β-lactamase-producing Escherichia coli from Norwegian livestock
    Sunde, M.
    Tharaldsen, H.
    Solheim, H.
    Norstroem, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S272 - S272
  • [35] Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in a remote region of Niger
    Jacquier, Herve
    Assao, Bachir
    Chau, Francoise
    Guindo, Ousmane
    Condamine, Benedicte
    Magnan, Melanie
    Bridier-Nahmias, Antoine
    Sayingoza-Makombe, Nathan
    Moumouni, Aissatou
    Page, Anne-Laure
    Langendorf, Celine
    Coldiron, Matthew E.
    Denamur, Erick
    de Lastours, Victoire
    JOURNAL OF INFECTION, 2023, 87 (03) : 199 - 209
  • [36] Prospective Validation of Cessation of Contact Precautions for Extended-Spectrum β-Lactamase-Producing Escherichia coli
    Tschudin-Sutter, Sarah
    Frei, Reno
    Schwahn, Friedbert
    Tomic, Milanka
    Conzelmann, Martin
    Stranden, Anne
    Widmer, Andreas F.
    EMERGING INFECTIOUS DISEASES, 2016, 22 (06) : 1094 - 1097
  • [37] Risk Factors for Bloodstream Infections due to Extended-spectrum β-lactamase-producing Escherichia coli
    Wu, Un-In
    Yang, Ching-Shiang
    Chen, Wan-Chin
    Chen, Yee-Chun
    Chang, Shan-Chwen
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2010, 43 (04) : 310 - 316
  • [38] Polyclonal distribution of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Stockholm
    Titelman, E.
    Iversen, A.
    Lagergren, A.
    Kuhn, I.
    Kahlmeter, G.
    Giske, C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S90 - S91
  • [39] Extended-spectrum β-lactamase-producing organisms
    Falagas, M. E.
    Karageorgopoulos, D. E.
    JOURNAL OF HOSPITAL INFECTION, 2009, 73 (04) : 345 - 354
  • [40] Extended-spectrum β-lactamase-producing Escherichia coli (vol 20, pg 404, 2020)
    Huang, Y.
    Zeng, L.
    Doi, Y.
    Lv, L.
    Liu, J-H
    LANCET INFECTIOUS DISEASES, 2020, 20 (08): : E180 - E180